Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

CD55 Antikörper

Dieses Anti-CD55-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von CD55 in ICFC. Geeignet für Human.
Produktnummer ABIN2664770

Kurzübersicht für CD55 Antikörper (ABIN2664770)

Target

Alle CD55 Antikörper anzeigen
CD55 (Complement Decay-Accelerating Factor (CD55))

Reaktivität

  • 135
  • 33
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
Human

Wirt

  • 96
  • 65
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
Maus

Klonalität

  • 114
  • 62
  • 2
Monoklonal

Konjugat

  • 81
  • 18
  • 16
  • 13
  • 6
  • 4
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser CD55 Antikörper ist unkonjugiert

Applikation

  • 103
  • 94
  • 41
  • 36
  • 36
  • 23
  • 17
  • 15
  • 14
  • 14
  • 14
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
Intracellular Flow Cytometry (ICFC)

Klon

JS11
  • Aufreinigung

    The antibody was purified by affinity chromatography.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.5 mg/mL

    Buffer

    Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    The antibody solution should be stored undiluted between 2°C and 8°C.
  • Target

    CD55 (Complement Decay-Accelerating Factor (CD55))

    Andere Bezeichnung

    CD55

    Hintergrund

    CD55 is a 60-70 kD glycosylphosphatidylinositol (GPI)-anchored single chain glycoprotein also known as decay-accelerating factor (DAF). It is expressed on hematopoietic cells including erythrocytes and many non-hematopoietic cells. CD55 accelerates the dissociation of the components of the C3-convertases (namely C2a from C4b in the C4bC2a complex, a C3-convertase of the classical pathway, and factor Bb from the C3bBb complex, a C3-convertase of the alternative pathway) to protect cells from inappropriate damage caused by autologous complement. CD55 has been reported to reduce the efficiency of NK cell lysis and induce signal transduction in T cells. CD55 has also been shown to interact with CD97 and bind to Coxsackie and Echovirus.

    Pathways

    Komplementsystem, Regulation of Leukocyte Mediated Immunity
Sie sind hier:
Chat with us!